We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

28 hedge funds and large institutions have $7.45M invested in ImmuCell in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $7.2M → $7.45M (+$255K)

0% more funds holding

Funds holding: 28 → 28 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.22% less ownership

Funds ownership: 10.36% → 10.14% (-0.22%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
+$591K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$123K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$42.1K
4
FHA
Flagship Harbor Advisors
Massachusetts
+$31K
5
Morgan Stanley
Morgan Stanley
New York
+$7.8K

Top Sellers

Rank Fund Capital Flow
1
WCM
Wedge Capital Management
North Carolina
-$197K
2
Renaissance Technologies
Renaissance Technologies
New York
-$91.9K
3
BlackRock
BlackRock
New York
-$69.5K
4
PCM
Perritt Capital Management
Illinois
-$48.8K
5
OSAM
O'Shaughnessy Asset Management
Connecticut
-$12.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.69M -$91.9K -9,422 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.4M +$123K +12,625 +9%
OMC
3
Overbrook Management Corp
New York
$829K -$1.95K -200 -0.2%
BL
4
Bleichroeder LP
New York
$576K +$591K +60,607 New
Morgan Stanley
5
Morgan Stanley
New York
$531K +$7.8K +800 +1%
PCM
6
Perritt Capital Management
Illinois
$475K -$48.8K -5,000 -9%
SFS
7
Strategic Financial Services
New York
$285K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$194K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$184K +$42.1K +4,312 +29%
SRC
10
Shufro Rose & Co
New York
$170K – – –
FHA
11
Flagship Harbor Advisors
Massachusetts
$168K +$31K +3,180 +22%
HighTower Advisors
12
HighTower Advisors
Illinois
$150K – – –
PP
13
Prosperity Planning
Missouri
$143K – – –
Northern Trust
14
Northern Trust
Illinois
$128K – – –
BlackRock
15
BlackRock
New York
$115K -$69.5K -7,124 -37%
MA
16
Minerva Advisors
Pennsylvania
$113K – – –
Envestnet Asset Management
17
Envestnet Asset Management
Illinois
$106K – – –
Mercer Global Advisors
18
Mercer Global Advisors
Colorado
$106K – – –
Bank of America
19
Bank of America
North Carolina
$20K -$215 -22 -1%
UBS Group
20
UBS Group
Switzerland
$20K – – –
HPC
21
HM Payson & Co
Maine
$19K – – –
OSAM
22
O'Shaughnessy Asset Management
Connecticut
$15K -$12.5K -1,277 -45%
US Bancorp
23
US Bancorp
Minnesota
$6K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$4K -$3.12K -320 -43%
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
$2K – – –
1
2

ICCC Hedge Fund Activity: Q2 2021 in Review

28 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2021, worth a combined $7.45M — up 3.5% from $7.2M a quarter earlier.

Fund positioning in ICCC was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was Bleichroeder LP, opening a new position worth an estimated $591K. The largest seller was Wedge Capital Management, exiting entirely with an estimated $197K sold.

  • 28 institutional investors held ImmuCell (ICCC) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $7.45M of ImmuCell stock for Q2 2021, up 3.5% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest ImmuCell buyer in Q2 2021 was Bleichroeder LP, an estimated $591K added.
  • The largest ImmuCell seller in Q2 2021 was Wedge Capital Management, an estimated $197K sold.

Based on aggregated 13F filings for Q2 2021.